We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
- Authors
on behalf of the CETLAM and PETHEMA groups; CETLAM and PETHEMA groups; Boluda, Blanca; Rodríguez-Veiga, Rebeca; Moscardó, Federico; Martínez-Cuadrón, David; Cordón, Lourdes; Sempere, Amparo; Montesinos, Pau; Sanz, Miguel A.; Garrido, Ana; Benavente, Celina; Pérez-Simón, José Antonio; Martínez, Pilar; Jiménez-Ubieto, Ana; Bergua, Juan; Prieto-Delgado, Julio; Esteve, Jordi; Díaz-Beyá, Marina; Vives, Susana
- Abstract
The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández in the original article.The original version of this article was revised: The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández.
- Subjects
ACUTE myeloid leukemia; FLUDARABINE; IDARUBICIN
- Publication
Annals of Hematology, 2018, Vol 97, Issue 5, p923
- ISSN
0939-5555
- Publication type
journal article
- DOI
10.1007/s00277-018-3229-5